chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Oedema, Rash, Rash macular, Scab
Clinical narrative: Edema in hands and the back of her knees and thighs us; on nipple of right breast was a piece of hard crust/looked like a clear scab; she noticed a dark brown spot on the nipple; rash; swollen; warm; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (swollen), FEELING HOT (warm), SCAB (on nipple of right breast was a piece of hard crust/looked like a clear scab), RASH MACULAR (she noticed a dark brown spot on the nipple) and OEDEMA (Edema in hands and the back of her knees and thighs) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Breast cyst. Concurrent medical conditions included Contrast media allergy.   On 03-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Mar-2021, the patient experienced SWELLING (swollen), FEELING HOT (warm) and RASH (rash). On 09-Mar-2021, the patient experienced SCAB (on nipple of right breast was a piece of hard crust/looked like a clear scab) and RASH MACULAR (she noticed a dark brown spot on the nipple). On an unknown date, the patient experienced OEDEMA (Edema in hands and the back of her knees and thighs). At the time of the report, SWELLING (swollen), FEELING HOT (warm), SCAB (on nipple of right breast was a piece of hard crust/looked like a clear scab), RASH MACULAR (she noticed a dark brown spot on the nipple), OEDEMA (Edema in hands and the back of her knees and thighs) and RASH (rash) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable.  No concomitant medications were reported. Treatment information was unknown.   Most recent FOLLOW-UP information incorporated above includes: On 07-Jul-2021: Follow-up information received on 07-JUL-2021 contains Significant information- added a new event Edema
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling
Clinical narrative: Edema in hands and the back of her knees and thighs us; on nipple of right breast was a piece of hard crust/looked like a clear scab; she noticed a dark brown spot on the nipple; rash; swollen; warm; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (swollen), FEELING HOT (warm), SCAB (on nipple of right breast was a piece of hard crust/looked like a clear scab), RASH MACULAR (she noticed a dark brown spot on the nipple) and OEDEMA (Edema in hands and the back of her knees and thighs) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Breast cyst. Concurrent medical conditions included Contrast media allergy.   On 03-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Mar-2021, the patient experienced SWELLING (swollen), FEELING HOT (warm) and RASH (rash). On 09-Mar-2021, the patient experienced SCAB (on nipple of right breast was a piece of hard crust/looked like a clear scab) and RASH MACULAR (she noticed a dark brown spot on the nipple). On an unknown date, the patient experienced OEDEMA (Edema in hands and the back of her knees and thighs). At the time of the report, SWELLING (swollen), FEELING HOT (warm), SCAB (on nipple of right breast was a piece of hard crust/looked like a clear scab), RASH MACULAR (she noticed a dark brown spot on the nipple), OEDEMA (Edema in hands and the back of her knees and thighs) and RASH (rash) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable.  No concomitant medications were reported. Treatment information was unknown.   Most recent FOLLOW-UP information incorporated above includes: On 07-Jul-2021: Follow-up information received on 07-JUL-2021 contains Significant information- added a new event Edema
Sex: F
Vaccine: COVID19
Symptoms: Confusional state, Feeling abnormal, Illness, Pain, Visual impairment
Clinical narrative: Sick; left side hurt extremely; mind was messed up; confused; vision go bad; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Sick), PAIN (left side hurt extremely), FEELING ABNORMAL (mind was messed up), CONFUSIONAL STATE (confused) and VISUAL IMPAIRMENT (vision go bad) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (Sick), PAIN (left side hurt extremely), FEELING ABNORMAL (mind was messed up), CONFUSIONAL STATE (confused) and VISUAL IMPAIRMENT (vision go bad). At the time of the report, ILLNESS (Sick), PAIN (left side hurt extremely), FEELING ABNORMAL (mind was messed up), CONFUSIONAL STATE (confused) and VISUAL IMPAIRMENT (vision go bad) had resolved. Not Provided          Concomitant product use was not provided by the reporter. Treatment information was not provided.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Injection site swelling, Peripheral swelling
Clinical narrative: Swelling down her arm; Pain around the injection site; Swelling around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swelling down her arm), INJECTION SITE PAIN (Pain around the injection site) and INJECTION SITE SWELLING (Swelling around the injection site) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, the patient experienced PERIPHERAL SWELLING (Swelling down her arm), INJECTION SITE PAIN (Pain around the injection site) and INJECTION SITE SWELLING (Swelling around the injection site). At the time of the report, PERIPHERAL SWELLING (Swelling down her arm), INJECTION SITE PAIN (Pain around the injection site) and INJECTION SITE SWELLING (Swelling around the injection site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator  No treatment medications provided by the reporter.
Sex: U
Vaccine: COVID19
Symptoms: Erythema, Rash
Clinical narrative: Redness; Rashes; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other and describes the occurrence of ERYTHEMA (Redness) and RASH (Rashes) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (Redness) and RASH (Rashes).        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site rash, Vaccination site urticaria
Clinical narrative: small rash around injection site; hives only at injection site that were red, raised, and itchy; hives only at injection site that were red, raised, and itchy; hives only at injection site that were red, raised, and itchy; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (small rash around injection site), VACCINATION SITE PRURITUS (hives only at injection site that were red, raised, and itchy), VACCINATION SITE URTICARIA (hives only at injection site that were red, raised, and itchy) and VACCINATION SITE ERYTHEMA (hives only at injection site that were red, raised, and itchy) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced VACCINATION SITE RASH (small rash around injection site), VACCINATION SITE PRURITUS (hives only at injection site that were red, raised, and itchy), VACCINATION SITE URTICARIA (hives only at injection site that were red, raised, and itchy) and VACCINATION SITE ERYTHEMA (hives only at injection site that were red, raised, and itchy). The patient was treated with LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, VACCINATION SITE RASH (small rash around injection site), VACCINATION SITE PRURITUS (hives only at injection site that were red, raised, and itchy), VACCINATION SITE URTICARIA (hives only at injection site that were red, raised, and itchy) and VACCINATION SITE ERYTHEMA (hives only at injection site that were red, raised, and itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Erythema, Headache, Pain in extremity
Clinical narrative: fever; red face; chills; Pain in arm; headache; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), ERYTHEMA (red face), CHILLS (chills), PAIN IN EXTREMITY (Pain in arm) and HEADACHE (headache) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Mar-2021, the patient experienced PYREXIA (fever), ERYTHEMA (red face), CHILLS (chills), PAIN IN EXTREMITY (Pain in arm) and HEADACHE (headache). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, PYREXIA (fever), ERYTHEMA (red face), CHILLS (chills), PAIN IN EXTREMITY (Pain in arm) and HEADACHE (headache) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Mar-2021, Body temperature: 102.4 (Inconclusive) 102.4.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication were provided.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: fever; red face; chills; Pain in arm; headache; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), ERYTHEMA (red face), CHILLS (chills), PAIN IN EXTREMITY (Pain in arm) and HEADACHE (headache) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Mar-2021, the patient experienced PYREXIA (fever), ERYTHEMA (red face), CHILLS (chills), PAIN IN EXTREMITY (Pain in arm) and HEADACHE (headache). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, PYREXIA (fever), ERYTHEMA (red face), CHILLS (chills), PAIN IN EXTREMITY (Pain in arm) and HEADACHE (headache) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Mar-2021, Body temperature: 102.4 (Inconclusive) 102.4.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication were provided.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Myalgia, Pyrexia
Clinical narrative: chills; body aches; muscle ache; headache; fever; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), MYALGIA (body aches), MYALGIA (muscle ache), HEADACHE (headache) and PYREXIA (fever) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetic.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHILLS (chills), MYALGIA (body aches), MYALGIA (muscle ache), HEADACHE (headache) and PYREXIA (fever). At the time of the report, CHILLS (chills), MYALGIA (body aches), MYALGIA (muscle ache), HEADACHE (headache) and PYREXIA (fever) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain
Clinical narrative: Soreness at injection site; Redness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Soreness at injection site) and VACCINATION SITE ERYTHEMA (Redness at injection site) in an 87-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced VACCINATION SITE PAIN (Soreness at injection site) and VACCINATION SITE ERYTHEMA (Redness at injection site). At the time of the report, VACCINATION SITE PAIN (Soreness at injection site) and VACCINATION SITE ERYTHEMA (Redness at injection site) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient takes medications for cholesterol and blood pressure. No Treatment Medication Was Provided.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Tachycardia, Vaccination site pain
Clinical narrative: Arm (injection site) is tenderness; fast heartbeat; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Arm (injection site) is tenderness) and TACHYCARDIA (fast heartbeat) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     Concurrent medical conditions included Thyroid disorder NOS and Blood pressure high.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Arm (injection site) is tenderness) and TACHYCARDIA (fast heartbeat). At the time of the report, VACCINATION SITE PAIN (Arm (injection site) is tenderness) and TACHYCARDIA (fast heartbeat) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications are taken for thyroid and high blood pressure. No treatment information was reported.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031M20A and 029L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 17-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PYREXIA (Fever). At the time of the report, PYREXIA (Fever) outcome was unknown. Not Provided          No relevant concomitant medications reported.  No treatment information was provided.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: had hives over much of her body; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (had hives over much of her body) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced URTICARIA (had hives over much of her body). At the time of the report, URTICARIA (had hives over much of her body) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  No treatment information was reported.
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Illness, Limb discomfort
Clinical narrative: felt like he was hit by a truck; stiffnes after second shot; covid-19 positive; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (felt like he was hit by a truck), LIMB DISCOMFORT (stiffnes after second shot) and COVID-19 (covid-19 positive) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ILLNESS (felt like he was hit by a truck), LIMB DISCOMFORT (stiffnes after second shot) and COVID-19 (covid-19 positive). The patient was treated with ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. At the time of the report, ILLNESS (felt like he was hit by a truck), LIMB DISCOMFORT (stiffnes after second shot) and COVID-19 (covid-19 positive) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) Positive.         No Concomitant medications were provided    This case was linked to MOD-2021-029810 (Patient Link).
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Illness, Pain, Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: pain in her head but not a headache; shooting pain on top of head; feels slightly under the weather; itching at injection area; swollen at injection area; large dark red area by injection site; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (pain in her head but not a headache; shooting pain on top of head), ILLNESS (feels slightly under the weather), VACCINATION SITE PRURITUS (itching at injection area), VACCINATION SITE SWELLING (swollen at injection area) and VACCINATION SITE ERYTHEMA (large dark red area by injection site) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Mar-2021, the patient experienced PAIN (pain in her head but not a headache; shooting pain on top of head), ILLNESS (feels slightly under the weather), VACCINATION SITE PRURITUS (itching at injection area), VACCINATION SITE SWELLING (swollen at injection area) and VACCINATION SITE ERYTHEMA (large dark red area by injection site). On 09-Mar-2021, PAIN (pain in her head but not a headache; shooting pain on top of head) had resolved. At the time of the report, ILLNESS (feels slightly under the weather), VACCINATION SITE PRURITUS (itching at injection area), VACCINATION SITE SWELLING (swollen at injection area) and VACCINATION SITE ERYTHEMA (large dark red area by injection site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant drugs reported.  No treatment reported.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Fluid retention, Weight increased
Clinical narrative: Rapid weight gain; Fluid retention; This spontaneous case was reported by a pharmacist and describes the occurrence of WEIGHT INCREASED (Rapid weight gain) and FLUID RETENTION (Fluid retention) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013A21A and 004M20A) for COVID-19 vaccination.     Concurrent medical conditions included Bedridden.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced WEIGHT INCREASED (Rapid weight gain) and FLUID RETENTION (Fluid retention). At the time of the report, WEIGHT INCREASED (Rapid weight gain) and FLUID RETENTION (Fluid retention) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant and treatment medications were reported.
Age: 82.0
Sex: U
Vaccine: COVID19
Symptoms: Erythema, Pruritus
Clinical narrative: Leg has been red; Leg has been itchy; This spontaneous case was reported by a patient and describes the occurrence of ERYTHEMA (Leg has been red) and PRURITUS (Leg has been itchy) in an 82-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included VALSARTAN, METOPROLOL, OMEPRAZOLE, ATORVASTATIN, TAMSULOSIN, INSULIN HUMAN, INSULIN HUMAN INJECTION, ISOPHANE (HUMULIN 10/90), BRIMONIDINE TARTRATE, BRINZOLAMIDE (SIMBRINZA), LATANOPROST, EMPAGLIFLOZIN (JARDIANCE), ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) and IRON for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced ERYTHEMA (Leg has been red) and PRURITUS (Leg has been itchy). At the time of the report, ERYTHEMA (Leg has been red) and PRURITUS (Leg has been itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications were reported.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Chest pain, Illness, Lymph node pain, Myalgia
Clinical narrative: did not get her 2nd dose; Lymph node pain; Muscle aches; Vomiting; Chest pain; Pain in back; Started to feel sick; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (Chest pain), BACK PAIN (Pain in back), ILLNESS (Started to feel sick), PRODUCT DOSE OMISSION ISSUE (did not get her 2nd dose) and LYMPH NODE PAIN (Lymph node pain) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19. Concomitant products included VALSARTAN for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced CHEST PAIN (Chest pain), BACK PAIN (Pain in back), ILLNESS (Started to feel sick), LYMPH NODE PAIN (Lymph node pain), MYALGIA (Muscle aches) and VOMITING (Vomiting). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (did not get her 2nd dose). At the time of the report, CHEST PAIN (Chest pain), BACK PAIN (Pain in back), ILLNESS (Started to feel sick), PRODUCT DOSE OMISSION ISSUE (did not get her 2nd dose), LYMPH NODE PAIN (Lymph node pain), MYALGIA (Muscle aches) and VOMITING (Vomiting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information included Tylenol    Most recent FOLLOW-UP information incorporated above includes: On 02-May-2021: No specific follow-up information recorded.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue, Vomiting
Clinical narrative: did not get her 2nd dose; Lymph node pain; Muscle aches; Vomiting; Chest pain; Pain in back; Started to feel sick; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (Chest pain), BACK PAIN (Pain in back), ILLNESS (Started to feel sick), PRODUCT DOSE OMISSION ISSUE (did not get her 2nd dose) and LYMPH NODE PAIN (Lymph node pain) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19. Concomitant products included VALSARTAN for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced CHEST PAIN (Chest pain), BACK PAIN (Pain in back), ILLNESS (Started to feel sick), LYMPH NODE PAIN (Lymph node pain), MYALGIA (Muscle aches) and VOMITING (Vomiting). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (did not get her 2nd dose). At the time of the report, CHEST PAIN (Chest pain), BACK PAIN (Pain in back), ILLNESS (Started to feel sick), PRODUCT DOSE OMISSION ISSUE (did not get her 2nd dose), LYMPH NODE PAIN (Lymph node pain), MYALGIA (Muscle aches) and VOMITING (Vomiting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information included Tylenol    Most recent FOLLOW-UP information incorporated above includes: On 02-May-2021: No specific follow-up information recorded.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Influenza like illness
Clinical narrative: Felt like he had flu like symptoms that felt like when he had covid; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Felt like he had flu like symptoms that felt like when he had covid) in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (He had COVID in November.).    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (Felt like he had flu like symptoms that felt like when he had covid). On 26-Feb-2021, INFLUENZA LIKE ILLNESS (Felt like he had flu like symptoms that felt like when he had covid) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product used was not provided.  No treatment information was reported.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: Warm to the touch knot at the site of injection; Itchy knot at the site of injection; Red knot at the site of injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Warm to the touch knot at the site of injection), VACCINATION SITE PRURITUS (Itchy knot at the site of injection) and VACCINATION SITE ERYTHEMA (Red knot at the site of injection) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Warm to the touch knot at the site of injection), VACCINATION SITE PRURITUS (Itchy knot at the site of injection) and VACCINATION SITE ERYTHEMA (Red knot at the site of injection). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (Warm to the touch knot at the site of injection), VACCINATION SITE PRURITUS (Itchy knot at the site of injection) and VACCINATION SITE ERYTHEMA (Red knot at the site of injection) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Dry throat, Fatigue, Loss of personal independence in daily activities, Myalgia
Clinical narrative: has to rest to be productive; dry throat; soreness in middle back; tired; muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (has to rest to be productive), DRY THROAT (dry throat), BACK PAIN (soreness in middle back), FATIGUE (tired) and MYALGIA (muscle pain) in an 85-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included MYCOPHENOLATE MOFETIL HYDROCHLORIDE (CELLCEPT [MYCOPHENOLATE MOFETIL HYDROCHLORIDE]) for an unknown indication.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Mar-2021, the patient experienced LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (has to rest to be productive), DRY THROAT (dry throat), BACK PAIN (soreness in middle back), FATIGUE (tired) and MYALGIA (muscle pain). At the time of the report, LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (has to rest to be productive), DRY THROAT (dry throat), BACK PAIN (soreness in middle back), FATIGUE (tired) and MYALGIA (muscle pain) outcome was unknown.            No treatment medications were reported.
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Vomiting
Clinical narrative: Throwing up; Injection site pain; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (Injection site pain) and VOMITING (Throwing up) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced INJECTION SITE PAIN (Injection site pain). On an unknown date, the patient experienced VOMITING (Throwing up). At the time of the report, INJECTION SITE PAIN (Injection site pain) and VOMITING (Throwing up) outcome was unknown. Not Provided          No concomitant and treatment medications were reported.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Product dose omission issue, Rash erythematous, Vaccination site pain, Vaccination site swelling
Clinical narrative: pain in her right leg starting with knee and passed through the ankle; arm pain; she hasn't received the 2nd shot yet; swollen injection site; whole arm hurt (site of injection); arm has a red rash; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (arm has a red rash), PAIN IN EXTREMITY (pain in her right leg starting with knee and passed through the ankle), PAIN IN EXTREMITY (arm pain), PRODUCT DOSE OMISSION ISSUE (she hasn't received the 2nd shot yet) and VACCINATION SITE SWELLING (swollen injection site) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced RASH ERYTHEMATOUS (arm has a red rash), VACCINATION SITE SWELLING (swollen injection site) and VACCINATION SITE PAIN (whole arm hurt (site of injection)). On an unknown date, the patient experienced PAIN IN EXTREMITY (pain in her right leg starting with knee and passed through the ankle), PAIN IN EXTREMITY (arm pain) and PRODUCT DOSE OMISSION ISSUE (she hasn't received the 2nd shot yet). At the time of the report, RASH ERYTHEMATOUS (arm has a red rash), PAIN IN EXTREMITY (pain in her right leg starting with knee and passed through the ankle), PAIN IN EXTREMITY (arm pain), PRODUCT DOSE OMISSION ISSUE (she hasn't received the 2nd shot yet), VACCINATION SITE SWELLING (swollen injection site) and VACCINATION SITE PAIN (whole arm hurt (site of injection)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided No Treatment information provided    Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: The Significant follow up case was received on 03-MAY-2021. Events were updated.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: Low grade fever 99.1-99.4; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Low grade fever 99.1-99.4) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L208) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Mar-2021, the patient experienced PYREXIA (Low grade fever 99.1-99.4). At the time of the report, PYREXIA (Low grade fever 99.1-99.4) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 99.1-99.4 High.         No concomitant medications were reported.  No treatment information was reported.   Reporter did not allow further contact
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Body temperature, Gait inability, Pyrexia
Clinical narrative: experiencing fever continued the fever for 6-7 days and measured always between 99-100 degree; "horrible, weak and hardly able to walk; felt "horrible, weak; This spontaneous case was reported by a consumer and describes the occurrence of GAIT INABILITY ("horrible, weak and hardly able to walk), ASTHENIA (felt "horrible, weak) and PYREXIA (experiencing fever continued the fever for 6-7 days and measured always between 99-100 degree) in an 85-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Neck surgery (plate put in) on 15-Jan-2021. Concurrent medical conditions included Blood pressure abnormal. Concomitant products included ATORVASTATIN CALCIUM (STATIN [ATORVASTATIN CALCIUM]) and ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Feb-2021, the patient experienced GAIT INABILITY ("horrible, weak and hardly able to walk) and ASTHENIA (felt "horrible, weak). On 27-Feb-2021, the patient experienced PYREXIA (experiencing fever continued the fever for 6-7 days and measured always between 99-100 degree). On 05-Mar-2021, PYREXIA (experiencing fever continued the fever for 6-7 days and measured always between 99-100 degree) had resolved. At the time of the report, GAIT INABILITY ("horrible, weak and hardly able to walk) and ASTHENIA (felt "horrible, weak) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 99-100 (High) 99-100.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 in response to the events was not Applicable.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site rash
Clinical narrative: it was very sore; there was a rash there; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (it was very sore) and VACCINATION SITE RASH (there was a rash there) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included SULFASALAZINE for an unknown indication.    On 27-Feb-2019, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Feb-2021, the patient experienced VACCINATION SITE PAIN (it was very sore) and VACCINATION SITE RASH (there was a rash there). At the time of the report, VACCINATION SITE PAIN (it was very sore) and VACCINATION SITE RASH (there was a rash there) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   Treatment details include paracetamol.  Concomitant medications include Sulfasalazine, Hormonal medicine and cholesterol medicine.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Diarrhoea, Muscle strain, Muscular weakness, Pain
Clinical narrative: diarrhea; pain in the shoulder; felt like strained muscle; aching and throbbing in the shoulder; can not raise arm above shoulder height; feels like loss of muscle control; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), ARTHRALGIA (pain in the shoulder), MUSCLE STRAIN (felt like strained muscle), PAIN (aching and throbbing in the shoulder) and VACCINATION SITE MOVEMENT IMPAIRMENT (can not raise arm above shoulder height) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (diarrhea), ARTHRALGIA (pain in the shoulder), MUSCLE STRAIN (felt like strained muscle), PAIN (aching and throbbing in the shoulder), VACCINATION SITE MOVEMENT IMPAIRMENT (can not raise arm above shoulder height) and MUSCULAR WEAKNESS (feels like loss of muscle control). At the time of the report, DIARRHOEA (diarrhea), ARTHRALGIA (pain in the shoulder), MUSCLE STRAIN (felt like strained muscle), PAIN (aching and throbbing in the shoulder), VACCINATION SITE MOVEMENT IMPAIRMENT (can not raise arm above shoulder height) and MUSCULAR WEAKNESS (feels like loss of muscle control) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided No Treatment information provided
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site movement impairment
Clinical narrative: diarrhea; pain in the shoulder; felt like strained muscle; aching and throbbing in the shoulder; can not raise arm above shoulder height; feels like loss of muscle control; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), ARTHRALGIA (pain in the shoulder), MUSCLE STRAIN (felt like strained muscle), PAIN (aching and throbbing in the shoulder) and VACCINATION SITE MOVEMENT IMPAIRMENT (can not raise arm above shoulder height) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (diarrhea), ARTHRALGIA (pain in the shoulder), MUSCLE STRAIN (felt like strained muscle), PAIN (aching and throbbing in the shoulder), VACCINATION SITE MOVEMENT IMPAIRMENT (can not raise arm above shoulder height) and MUSCULAR WEAKNESS (feels like loss of muscle control). At the time of the report, DIARRHOEA (diarrhea), ARTHRALGIA (pain in the shoulder), MUSCLE STRAIN (felt like strained muscle), PAIN (aching and throbbing in the shoulder), VACCINATION SITE MOVEMENT IMPAIRMENT (can not raise arm above shoulder height) and MUSCULAR WEAKNESS (feels like loss of muscle control) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided No Treatment information provided
Sex: M
Vaccine: COVID19
Symptoms: Joint swelling, Lymphadenopathy, Vaccination site pain
Clinical narrative: left lymph nodes swelling at left armpit; swelling in both left and right ankle; soreness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of JOINT SWELLING (swelling in both left and right ankle), VACCINATION SITE PAIN (soreness at the injection site) and LYMPHADENOPATHY (left lymph nodes swelling at left armpit) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     The patient's past medical history included Pacemaker insertion (cardiac). Concurrent medical conditions included Hypertension (He takes medication for his hypertension and high cholesterol) and Cholesterol.   On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 24-Feb-2021, the patient experienced VACCINATION SITE PAIN (soreness at the injection site). On 01-Mar-2021, the patient experienced JOINT SWELLING (swelling in both left and right ankle). On 07-Mar-2021, the patient experienced LYMPHADENOPATHY (left lymph nodes swelling at left armpit). On 09-Mar-2021, LYMPHADENOPATHY (left lymph nodes swelling at left armpit) had resolved. At the time of the report, JOINT SWELLING (swelling in both left and right ankle) and VACCINATION SITE PAIN (soreness at the injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   treatment medication were provided that icing and elevating
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Urticaria, Vaccination site pruritus
Clinical narrative: slight itch lower extremeties; Hives; stomach cramping; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of URTICARIA (Hives), ABDOMINAL PAIN UPPER (stomach cramping) and VACCINATION SITE PRURITUS (slight itch lower extremeties) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L2) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Feb-2021, the patient experienced URTICARIA (Hives) and ABDOMINAL PAIN UPPER (stomach cramping). On 09-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (slight itch lower extremeties). The patient was treated with TRIAMCINOLONE at a dose of UNK,0.1% topical cream and LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) at an unspecified dose and frequency. On 04-Mar-2021, URTICARIA (Hives) and ABDOMINAL PAIN UPPER (stomach cramping) had resolved. At the time of the report, VACCINATION SITE PRURITUS (slight itch lower extremeties) outcome was unknown.            No concomitant medicines reported by reporter. Treatment medication includes shot of some sort of steroid(name unknown).
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: bright red itchy rash on chest; This spontaneous case was reported by a consumer and describes the occurrence of RASH (bright red itchy rash on chest) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included FLUOXETINE and FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE (ADVAIR) for an unknown indication.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (bright red itchy rash on chest). At the time of the report, RASH (bright red itchy rash on chest) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Patient was also taking clonidine 1.5mg hs concomitantly
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Nausea, Vomiting
Clinical narrative: Diarrhea; Nausea; vomiting; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), NAUSEA (Nausea) and VOMITING (vomiting) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. O31L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced DIARRHOEA (Diarrhea), NAUSEA (Nausea) and VOMITING (vomiting). The patient was treated with LOPERAMIDE HYDROCHLORIDE (IMODIUM) for Adverse event, at an unspecified dose and frequency and IBUPROFEN for Adverse event, at an unspecified dose and frequency. On 09-Mar-2021, DIARRHOEA (Diarrhea) had resolved. At the time of the report, NAUSEA (Nausea) and VOMITING (vomiting) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was unknown by the reporter,Expiration date is not provided. He did not provide any information for her health care provider. He consented for follow up with safety. He agreed on follow up with her Health Care Provider. Treatment medication include Imodium, Ibuprofen